
Cinven invests in Barentz
Cinven has acquired a majority stake in Barentz, a Dutch company specialising in the production of ingredients for the pharmaceutical, cosmetics and food industries.
Unquote understands that this is the last investment made by Cinven via its sixth fund, which closed on €7bn in June 2016 and is now fully deployed. In addition to the equity from the fund, a debt package composed of a term loan B and a revolving credit facility was provided to support the acquisition of Barentz.
Cinven launched a new buyout vehicle in 2018, Seventh Cinven Fund, which held a final close on €10bn in May 2019, exceeding its €8bn target. The fund focuses on European buyouts and selective North American investments, and targets six main sectors: business services, consumer, financial services, healthcare, industrials, telecommunications, media and technology. It plans to make 10-12 deals and deploy equity tickets from €200m.
The fund has already inked its first investment in life sciences supplies provider LGC, which was acquired by a consortium of Cinven, Astorg and the Abu Dhabi Investment Authority for £3bn earlier this month.
Cinven intends to boost Barentz's growth, both organically and through integrating acquisitions, as well as expand its operations into new geographies, and invest in its infrastructure and R&D capabilities.
Company
Established in 1953 and headquartered in Hoofddorp, Barentz is a speciality ingredients producer and distributor for the food, pharmaceutical, personal care and animal nutrition markets.
The company sources branded speciality ingredients from manufacturers worldwide and provides pre-mixing, blending, ingredient formulation and ingredient testing in its state-of-the-art production facilities based in Europe, North America and Asia.
Barentz has operations in more than 60 countries with a strong presence in Europe and Asia, and a growing presence in North America and Latin America. It employs 1,100 staff, sources ingredients from 1,000 suppliers and serves 15,000 customers. Unquote understands that the company generates revenues of around €1bn.
People
Cinven – Ben Osnabrug (partner).
Barentz – Hidde van der Wal (CEO).
Advisers
Equity – 1602 Capital Partners (corporate finance).
Latest News
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Multi-family office has seen strong appetite, with investor base growing since 2016 to more than 90 family offices, Meiping Yap told Unquote
Permira to take Ergomed private for GBP 703m
Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO
Partners Group to release IMs for Civica sale in mid-September
Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017
Change of mind: Sponsors take to de-listing their own assets
EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater